407 related articles for article (PubMed ID: 34584230)
1. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of
Nakahara T; Tsugawa S; Noda Y; Ueno F; Honda S; Kinjo M; Segawa H; Hondo N; Mori Y; Watanabe H; Nakahara K; Yoshida K; Wada M; Tarumi R; Iwata Y; Plitman E; Moriguchi S; de la Fuente-Sandoval C; Uchida H; Mimura M; Graff-Guerrero A; Nakajima S
Mol Psychiatry; 2022 Jan; 27(1):744-757. PubMed ID: 34584230
[TBL] [Abstract][Full Text] [Related]
2. Reduced
Wang J; Tang Y; Zhang T; Cui H; Xu L; Zeng B; Li Y; Li G; Li C; Liu H; Lu Z; Zhang J; Wang J
Neural Plast; 2016; 2016():3915703. PubMed ID: 28003912
[TBL] [Abstract][Full Text] [Related]
3. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
[TBL] [Abstract][Full Text] [Related]
4. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
[TBL] [Abstract][Full Text] [Related]
5. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
Kegeles LS; Mao X; Stanford AD; Girgis R; Ojeil N; Xu X; Gil R; Slifstein M; Abi-Dargham A; Lisanby SH; Shungu DC
Arch Gen Psychiatry; 2012 May; 69(5):449-59. PubMed ID: 22213769
[TBL] [Abstract][Full Text] [Related]
6. Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
Hjelmervik H; Craven AR; Sinceviciute I; Johnsen E; Kompus K; Bless JJ; Kroken RA; Løberg EM; Ersland L; Grüner R; Hugdahl K
Schizophr Bull; 2020 Apr; 46(3):633-642. PubMed ID: 31626702
[TBL] [Abstract][Full Text] [Related]
7. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
Merritt K; McGuire PK; Egerton A; ; Aleman A; Block W; Bloemen OJN; Borgan F; Bustillo JR; Capizzano AA; Coughlin JM; De la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galinska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes OD; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan M; Kim SY; Kunugi H; Lauriello J; Liemburg EJ; Mcilwain ME; Modinos G; Mouchlianitis ED; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone JM; Szulc A; Taylor R; Thakkar K; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H
JAMA Psychiatry; 2021 Jun; 78(6):667-681. PubMed ID: 33881460
[TBL] [Abstract][Full Text] [Related]
8. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
9. Excitatory and inhibitory responses in the brain to experimental pain: A systematic review of MR spectroscopy studies.
Archibald J; MacMillan EL; Enzler A; Jutzeler CR; Schweinhardt P; Kramer JLK
Neuroimage; 2020 Jul; 215():116794. PubMed ID: 32278899
[TBL] [Abstract][Full Text] [Related]
10. Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with schizophrenia: A
Ćurčić-Blake B; Bais L; Sibeijn-Kuiper A; Pijnenborg HM; Knegtering H; Liemburg E; Aleman A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():132-139. PubMed ID: 28546056
[TBL] [Abstract][Full Text] [Related]
11. Glutamate metabolites in treatment resistant schizophrenia: A meta-analysis and systematic review of
Kumar V; Manchegowda S; Jacob A; Rao NP
Psychiatry Res Neuroimaging; 2020 Jun; 300():111080. PubMed ID: 32279055
[TBL] [Abstract][Full Text] [Related]
12. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.
Thakkar KN; Rösler L; Wijnen JP; Boer VO; Klomp DW; Cahn W; Kahn RS; Neggers SF
Biol Psychiatry; 2017 Mar; 81(6):525-535. PubMed ID: 27316853
[TBL] [Abstract][Full Text] [Related]
13. Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders.
Lopes JJ; Carruthers SP; Meyer D; Dean B; Rossell SL
Aust N Z J Psychiatry; 2024 May; ():48674241254216. PubMed ID: 38812258
[TBL] [Abstract][Full Text] [Related]
14. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Moriguchi S; Takamiya A; Noda Y; Horita N; Wada M; Tsugawa S; Plitman E; Sano Y; Tarumi R; ElSalhy M; Katayama N; Ogyu K; Miyazaki T; Kishimoto T; Graff-Guerrero A; Meyer JH; Blumberger DM; Daskalakis ZJ; Mimura M; Nakajima S
Mol Psychiatry; 2019 Jul; 24(7):952-964. PubMed ID: 30315224
[TBL] [Abstract][Full Text] [Related]
15. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.
Soeiro-de-Souza MG; Henning A; Machado-Vieira R; Moreno RA; Pastorello BF; da Costa Leite C; Vallada H; Otaduy MC
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2221-9. PubMed ID: 26476706
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal trajectories of anterior cingulate glutamate and subclinical psychotic experiences in early adolescence: the impact of bullying victimization.
Okada N; Yahata N; Koshiyama D; Morita K; Sawada K; Kanata S; Fujikawa S; Sugimoto N; Toriyama R; Masaoka M; Koike S; Araki T; Kano Y; Endo K; Yamasaki S; Ando S; Nishida A; Hiraiwa-Hasegawa M; Edden RAE; Sawa A; Kasai K
Mol Psychiatry; 2024 Apr; 29(4):939-950. PubMed ID: 38182806
[TBL] [Abstract][Full Text] [Related]
17. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.
Kanaan AS; Gerasch S; García-García I; Lampe L; Pampel A; Anwander A; Near J; Möller HE; Müller-Vahl K
Brain; 2017 Jan; 140(1):218-234. PubMed ID: 28007998
[TBL] [Abstract][Full Text] [Related]
18. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
[TBL] [Abstract][Full Text] [Related]
19. Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.
Merritt K; McCutcheon RA; Aleman A; Ashley S; Beck K; Block W; Bloemen OJN; Borgan F; Boules C; Bustillo JR; Capizzano AA; Coughlin JM; David A; de la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galińska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes O; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan MS; Kim SY; King B; Kunugi H; Lauriello J; León-Ortiz P; Liemburg E; Mcilwain ME; Modinos G; Mouchlianitis E; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Patel T; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Reyes-Madrigal F; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone J; Szulc A; Taylor R; Thakkar KN; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H; McGuire P; Egerton A;
Mol Psychiatry; 2023 May; 28(5):2039-2048. PubMed ID: 36806762
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy.
Ritter C; Buchmann A; Müller ST; Volleberg M; Haynes M; Ghisleni C; Noeske R; Tuura R; Hasler G
JAMA Psychiatry; 2022 Dec; 79(12):1209-1216. PubMed ID: 36260322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
